Semaglutide’s Heart Benefits May Extend Beyond Weight Loss

Semaglutide is improving the heart health of millions—but how? Experts are stumped

<p>“Our analyses could not fully ascribe the effects of semaglutide on cardiovascular disease to known risk factors with any certainty,” one researcher said after exploring years of data. "These results suggest that semaglutide should be considered as a cardiovascular disease reduction drug and not just as a weight loss drug," </p>

Semaglutide’s heart benefits may extend beyond weight loss

Semaglutide is known to reduce the risk of serious heart disease. However, a new study published in the European Heart Journal today (Thursday) suggests that this effect cannot not be entirely explained by patients losing weight on the drug.

Weight loss alone does not explain lower heart disease risk for those on semaglutide

Semaglutide is known to reduce the risk of serious heart disease. However, a new study published in the European Heart Journal suggests that this effect cannot be entirely explained by patients losing weight on the drug.

Obesity drug heart benefits not just due to weight loss | News | The University of Edinburgh

The reduced risk of heart disease seen in people who are overweight or have obesity taking the weight loss drug semaglutide may not be due to a drop in weight alone, a study shows.